Matthew D Johnson Selected Research

Matthew D Johnson Research Topics

18	Parkinson Disease (Parkinson's Disease) 01/2024 - 11/2008
7	Essential Tremor (Essential Tremors) 01/2024 - 08/2012
5	Parkinsonian Disorders (Parkinsonism) 01/2021 - 07/2016
4	Tremor (Tremors) 03/2023 - 08/2012
4	Brain Diseases (Brain Disorder) 01/2018 - 01/2013
3	Inflammation (Inflammations) 10/2022 - 04/2016
3	Wounds and Injuries (Trauma) 05/2017 - 01/2006
3	Infections 07/2016 - 01/2016
2	Nervous System Diseases (Neurological Disorders) 01/2024 - 01/2013
2	Lung Diseases (Lung Disease) 09/2023 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2018 - 01/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2016 - 01/2006
2	Paresthesia (Dysesthesia) 08/2013 - 08/2012
2	Movement Disorders (Movement Disorder) 01/2013 - 04/2008
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2023
1	Comminuted Fractures 08/2023
1	Mental Disorders (Mental Disorder) 12/2022
1	Pain (Aches) 01/2022
1	Postoperative Pain 01/2022
1	Synostosis 08/2021
1	Craniosynostoses (Craniosynostosis) 08/2021
1	Surgical Wound Infection 05/2021
1	Torticollis (Wryneck) 01/2020
1	Rupture 04/2019
1	Osteoarthritis 01/2019
1	Brain Neoplasms (Brain Tumor) 05/2018
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Adenocarcinoma 02/2017
1	Whooping Cough (Pertussis) 01/2017
1	Gastritis 01/2017
1	Brain Edema (Cerebral Edema) 04/2016
1	Starvation 07/2015
1	Hypokinesia (Bradykinesia) 07/2012
1	AIDS-Related Complex (ARC) 08/2009
1	Dystonia (Limb Dystonia) 11/2008
1	Acidosis 01/2006

6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2018 - 07/2012
4	Therapeutic UsesIBA 01/2020 - 07/2012
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 01/2016
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2017
2	NeurotoxinsIBA 01/2021 - 11/2017
1	Inosine Monophosphate (IMP)IBA 08/2023
1	Indicators and Reagents (Reagents)IBA 12/2022
1	CannabidiolIBA 01/2022
1	cannabidiolic acidIBA 01/2022
1	Calcium Sulfate (Alabaster)IBA 05/2021
1	PyrrolidinesIBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	HarmalineIBA 01/2021
1	InflammasomesIBA 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 05/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	DisulfidesIBA 01/2017
1	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 01/2017
1	Pertussis ToxinIBA 01/2017
1	Neuroprotective AgentsIBA 04/2016
1	Polymyxins (Polymyxin)IBA 01/2016
1	NitrogenIBA 07/2015
1	iridium oxideIBA 01/2006

24	Deep Brain Stimulation 01/2024 - 04/2008
15	Therapeutics 03/2023 - 01/2006
7	Electrodes (Electrode) 03/2023 - 01/2006
2	Extracorporeal Membrane Oxygenation 09/2023 - 01/2022
2	Sutures (Suture) 08/2021 - 04/2019
1	Spinal Cord Stimulation 10/2023
1	Lung Transplantation 09/2023
1	General Anesthesia 10/2022
1	Osteotomy 01/2022
1	Transplantation 01/2022
1	Distraction Osteogenesis 08/2021
1	Orthopedic Procedures 05/2021
1	Implanted Electrodes 11/2017
1	Nasal Surgical Procedures 05/2017
1	Neoadjuvant Therapy 02/2017
1	Radiotherapy 01/2017
1	Operative Surgical Procedures 05/2016
1	Vagus Nerve Stimulation 04/2016
1	Injections 04/2015
1	Microelectrodes 01/2006